Real-World Applications
Neurodiagnoses is designed to provide actionable insights for a range of stakeholders in the neurodegenerative disease space.
For Clinicians
Enhancing Differential Diagnosis in Complex Cases
Move beyond symptom-based ambiguity. Neurodiagnoses provides a probabilistic assessment across multiple neurodegenerative diseases, supported by a deep, multi-modal evidence trail. It helps clarify complex presentations, such as differentiating between Alzheimer's Disease, Lewy Body Dementia, and Frontotemporal Dementia, especially in early stages.
For Medical Researchers
Accelerating Patient Stratification and Subtype Discovery
Analyze large, multi-modal datasets to uncover novel patient subgroups. The tridimensional annotation allows for stratification based not on clinical labels alone, but on shared etiological, molecular, and neuroanatomical profiles. This is crucial for understanding the biological drivers of heterogeneity in NDDs.
For Pharmaceutical & Clinical Trials
Optimizing Trial Design and Endpoint Monitoring
Improve the success rate of clinical trials with precision patient selection. Enroll participants based on confirmed molecular pathology (e.g., active amyloid or tau pathways) rather than just clinical scores. Use the system's quantitative annotations as sensitive biomarkers to monitor therapeutic response and treatment efficacy over time.